Results of the RADAR trial at 7.4 years of follow-up

The RADAR trial (also known as TROG 03.04) was a randomized trial of 6 months of androgen deprivation therapy (ADT) + radiation therapy versus 18 months of ADT + radiotherapy, with or without additional zoledronic acid therapy, in men with intermediate- and high-risk, locally advanced prostate cancer. … READ MORE …

Short-term outcomes after prostate cancer diagnosis and treatment in France

An article available in full on the Medscape web site provides an overview of short-term outcomes of > 43,000 men diagnosed with prostate cancer in France in 2009 and followed for 2 years based on data in the French national health insurance information system (SNIIRAM). You do need to register with Medscape to be able to read the article (but registration is free). … READ MORE …

To quest and test (or not to quest at all)

On The New York Times‘s “Well” blog site today. Dr. Barak Gaster takes on the complex issue of how doctors need to get better at talking to patients about the pros and cons of PSA testing. And there very definitely are pros and cons! I kid you not.

Your acne’s not preventing your risk for prostate cancer

Even though we don’t remember ever coming across this suggestion before, a few studies have apparently suggested that having acne is associated with a decreased risk for a diagnosis of prostate cancer — and aggressive forms of prostate cancer in particular. … READ MORE …

Sleep disruption, melatonin levels, and risk for prostate cancer

There have been a number of studies in the past suggesting that men who work night-shifts have a higher risk for prostate cancer than those of us who work during normal “day time” hours. … READ MORE …

One size doesn’t fit all when it comes to prostate cancer risk assessment

A newly published article in the journal Cancer is probably going to drive a number of readers of this blog to distraction — and for any number of good reasons, starting with the idea that all prostate cancer screening either should be or might be discontinued (as suggested by the USPSTF). … READ MORE …

If you’re already depressed, you may need help to make good decisions

In a rather less that surprising finding, a new paper in the Journal of Clinical Oncology reports that men with existing depressive disorders at the time of diagnosis with prostate cancer “are less likely to undergo definitive treatment and experience worse overall survival.” … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,154 other followers